[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356729-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356729-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-term-health-outcomes-in-older-recipients-of-blood-or-marrow-transplantation-a-report-from-the-bmtss","Long-term health outcomes in older recipients of blood or marrow transplantation - a report from the BMTSS","","Older patients (≥60 years) undergoing blood or marrow transplantation (BMT) represent a growing group at risk for late morbidity and mortality, yet long-term health and well-being have been insufficiently characterized. This study assessed ≥2-year BMT survivors (N=1581) treated between 1990 and 2014 and compared severe/life-threatening chronic conditions and health status with 594 age-matched sibling controls. Survivors showed higher prevalence of severe/life-threatening conditions, worse general health and functional outcomes, elevated overall mortality, and increased subsequent neoplasms, especially infection-related deaths and specific cancers.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-term-health-outcomes-in-older-recipients-of-blood-or-marrow-transplantation-a-report-from-the-bmtss/356729/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-term-health-outcomes-in-older-recipients-of-blood-or-marrow-transplantation-a-report-from-the-bmtss/356729.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-09","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",18,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"研究如何界定并识别老年BMT后的严重/危及生命的慢性健康问题？","Question",{"text":63,"@type":64},"研究使用《不良事件通用术语标准》(Common Terminology Criteria for Adverse Events)来识别严重/危及生命的慢性健康状况与致命慢性健康条件。","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"老年BMT幸存者与同胞对照在健康状况方面有哪些主要差异？",{"text":68,"@type":64},"老年BMT幸存者严重/危及生命状况的患病率更高（72% vs 51%），且更容易报告总体健康状况差、功能受损、活动受限以及虚弱。",{"name":70,"@type":61,"acceptedAnswer":71},"研究发现的长期死亡风险和后续肿瘤风险分别表现为哪些特点？",{"text":72,"@type":64},"幸存者的总体死亡标准化比值（SMR）为5.3，且感染相关死亡风险显著升高（SMR=35.2）。此外，幸存者出现后续肿瘤的风险也更高，且霍奇金淋巴瘤与黑色素瘤的发病率升高最为突出。","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356729,1790703521,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","REGULAR ARTICLE  \nLong-term health outcomes in older recipients of blood or marrow transplantation: a report from the BMTSS  \nRusha Bhandari, 1, 2 Qingrui Meng,3 Lindsey Hageman,3 Liton Francisco,3 Elizabeth Schlichting Ross,3 Nora Balas,3 Alysia Bosworth, 1 Ravi Bhatia,4 Wendy Landier,3 Daniel J. Weisdorf,5 F. Lennie Wong,1 Smita Bhatia,3 and Saro H. Armenian 1, 2  \n1 Department of Population Sciences and 2 Department of Pediatrics, City of Hope, Duarte, CA; 3 Institute for Cancer Outcomes and Survivorship, and 4 Division of Hematology, Oncology and Bone Marrow Transplantation, The University of Alabama at Birmingham, Birmingham, AL; and 5 Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN  \nKey Points  \n• Older recipients of BMT have a high burden of severe/lifethreatening conditions and poor health status compared with sibling controls.  \n• These findings emphasize the ongoing health care burden of survivors of BMT, particularly in the older population.  \nLittle is known about the long-term health and well-being of older (≥60 years) patients who received blood or marrow transplant (BMT), a growing population at risk for lateoccurring morbidity and mortality. This study included ≥2-year survivors (N=1581) who underwent BMT between 1990 and 2014 at age ≥60 years. Severe/life-threatening and fatal chronic health conditions were identified using Common Terminology Criteria for Adverse Events. Multivariable regression analysis compared the risk of severe/life-threatening health conditions and health status between survivors and 594 age-matched sibling controls. Standardized mortality ratios (SMRs) and, for subsequent malignant neoplasms, standardized incidence ratios (SIRs) were calculated and compared with the general population. The prevalence of severe/life-threatening conditions was 72% in survivors of BMT vs 51% in siblings (P\u003C .001), yielding 2.9-fold higher odds of severe/life-threatening conditions (95% confidence interval [CI], 2.2-3.7) among the survivors. Survivors were more likely to report poor general health (odds ratio [OR], 4.1 [95%CI, 2.8-6.0]), functional impairment (OR, 3.2 [95%CI, 2.5-4.0]), activity limitation (OR, 3.1 [95%CI, 2.4-3.9]), and frailty (OR, 3.5 [95% CI, 2.1-6.0]). Among survivors, the overall SMR was 5.3 (95%CI, 5.0-5.6) . There was an especially high risk of infection-related mortality (SMR=35.2 [95%CI, 30.3-40.6]) . Survivors had a 3.8-fold risk of subsequent neoplasms (95%CI, 3.5-4.2) relative to the general population, with incidence rates highest for Hodgkin lymphoma (SIR=18.5 [95%CI, 7.4-37.5]) and melanoma (SIR=7.4 [95%CI, 5.1-10.2]) . Older recipients of BMT have a high burden of severe/life-threatening conditions and poor health status compared with sibling controls, contributing to increased relative risk of premature mortality. These findings emphasize the ongoing health care burden of survivors of BMT, particularly in this older population.  \nSubmitted 18 September 2025; accepted 29 January 2026; prepublished online on Blood Advances First Edition 24 February 2026. [https://doi.org/10.1182/](https://doi.org/10.1182/)[ ](https://doi.org/10.1182/)[bloodadvances.2025018477](bloodadvances.2025018477.)[.](bloodadvances.2025018477.)  \nPresented in abstract form at the 66th annual meeting of the American Society of Hematology, San Diego, CA, 7 to 10 December 2024.  \nThe data sets generated and/or analyzed during this study are available from the corresponding author, Rusha Bhandari ([rbhandari@coh.org](rbhandari@coh.org)), on reasonable request.  \nThe full-text version of this article contains a data supplement.  \n© 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.  \n12 MAY 2026 • VOLUME 10, NUMBER 9 2951  \nIntroduction  \nAdvancement","cbCaipKTSPKa1Sfc","https://ap.wps.com/l/cbCaipKTSPKa1Sfc","pdf",756171,11,"English","# Key Points\n## Severe/life-threatening conditions and health status\n## Mortality and cause-specific risk\n## Subsequent malignant neoplasms\n## Rationale and study context","[{\"question\":\"研究如何界定并识别老年BMT后的严重/危及生命的慢性健康问题？\",\"answer\":\"研究使用《不良事件通用术语标准》(Common Terminology Criteria for Adverse Events)来识别严重/危及生命的慢性健康状况与致命慢性健康条件。\"},{\"question\":\"老年BMT幸存者与同胞对照在健康状况方面有哪些主要差异？\",\"answer\":\"老年BMT幸存者严重/危及生命状况的患病率更高（72% vs 51%），且更容易报告总体健康状况差、功能受损、活动受限以及虚弱。\"},{\"question\":\"研究发现的长期死亡风险和后续肿瘤风险分别表现为哪些特点？\",\"answer\":\"幸存者的总体死亡标准化比值（SMR）为5.3，且感染相关死亡风险显著升高（SMR=35.2）。此外，幸存者出现后续肿瘤的风险也更高，且霍奇金淋巴瘤与黑色素瘤的发病率升高最为突出。\"}]","Long-term health outcomes in older recipients of blood or marrow transplantation - a report from the BMTSS | PDF",1790126971,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2337805a567af9b66b06d128067a1d90.webp",983,1296,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6aa3a7b8efd52365aa1326a524363400.webp",982,1294,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ddf3ba5496de540f4931ee725bb6d568.webp",981,1293,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d5d9833f734056f7131449916f3253d0.webp",980,1292]